Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Neuromuscular and Structural Effects of Using Stretching During the Recovery Phase Between Sets of Upper and Lower-body Strength Training

20. juli 2026 opdateret af: Universidad Europea de Madrid

Efectos Neuromusculares y Estructurales de la utilización de Estiramientos en la Fase de recuperación Entre Series de Entrenamiento de la Fuerza de Los Miembros Superiores e Inferiores

Neuromuscular and structural effects of using stretching during the recovery phase between sets of upper and lower-body strength training

Studieoversigt

Undersøgelsestype

Interventionel

Tilmelding (Faktiske)

35

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

    • Madrid
      • Villaviciosa de Odón, Madrid, Spanien
        • Edificio D

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

  • Voksen

Tager imod sunde frivillige

Ja

Beskrivelse

Inclusion Criteria:

Male or female adults aged 18-30 years. Apparently healthy, with no medical conditions that contraindicate participation in resistance training.

A minimum of 6 consecutive months of resistance training experience. Regular resistance training participation of at least three sessions per week during the previous 6 months.

Previous experience performing the back squat and bench press exercises with correct technique.

Ability to perform maximal intended concentric velocity during resistance exercises.

Willingness to refrain from vigorous physical activity during the 24 hours preceding each testing and training session.

Ability and willingness to comply with all study procedures. Provision of written informed consent.

Exclusion Criteria:

Current musculoskeletal injury affecting the upper or lower limbs that limits participation in resistance training or testing.

Acute or chronic pain that is aggravated by the study exercises. Cardiovascular, neurological, metabolic, or other medical conditions that contraindicate vigorous physical exercise.

Current participation in another structured intervention study or clinical trial.

Inability to attend the scheduled assessments or training sessions. Failure to comply with the study protocol or training requirements. Withdrawal of informed consent at any stage of the study. Occurrence of an adverse event during the intervention that prevents continued participation.

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Behandling
  • Tildeling: Randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Ingen (Åben etiket)

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: Agonists stretching
Neuromuscular and structural effects of using AGONISTS stretching during the recovery phase between sets of upper and lower-body strength training
Neuromuscular and structural effects of using AGONISTS stretching during the recovery phase between sets of upper and lower-body strength training
Andre navne:
  • STRETCHING
Aktiv komparator: Antagonists stretching
Neuromuscular and structural effects of using ANTAGONISTS stretching during the recovery phase between sets of upper and lower-body strength training
Neuromuscular and structural effects of using ANTAGONISTS stretching during the recovery phase between sets of upper and lower-body strength training
Andre navne:
  • STRETCHING
Placebo komparator: Control
Neuromuscular and structural effects of NOT using stretching during the recovery phase between sets of upper and lower-body strength training
Neuromuscular and structural effects of using NOT stretching during the recovery phase between sets of upper and lower-body strength training
Andre navne:
  • STYRING

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Acute resistance-training performance: total number of repetitions
Tidsramme: First intervention session (Week 1), across the four training sets.
Total number of repetitions completed across four sets of bench press and back squat during the first intervention session. Participants will perform each set to momentary muscular failure at maximal intended concentric velocity, using individualized absolute loads corresponding to 75% of the estimated one-repetition maximum (1RM) for the bench press and 80% of the estimated 1RM for the back squat. Repetitions completed in each set and total repetitions per exercise will be recorded to compare the immediate effects of agonist stretching, antagonist stretching, and no stretching.
First intervention session (Week 1), across the four training sets.

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

20. september 2024

Primær færdiggørelse (Faktiske)

1. april 2026

Studieafslutning (Faktiske)

20. juni 2026

Datoer for studieregistrering

Først indsendt

20. juli 2026

Først indsendt, der opfyldte QC-kriterier

20. juli 2026

Først opslået (Faktiske)

23. juli 2026

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

23. juli 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

20. juli 2026

Sidst verificeret

1. september 2024

Mere information

Begreber relateret til denne undersøgelse

Andre undersøgelses-id-numre

  • 2024-495

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner